HOME >> BIOLOGY >> NEWS
Structure solved at Scripps shows how one human protein reduces potency of chemotherapy

ested in clinical trials as an adjuvant for chemotherapy. The idea is that these inhibitors could be administered at the same time as chemotherapy to make chemotherapy more effective.

"Having the structure solved allows us to make [inhibitors] that are [even] more selective," Pegg says.

The structure also provides a way of designing proteins to improve cancer treatments, says Tainer. The molecular details of the structure show how AGT could be modified to resist selective inhibitors. This could be used to protect critical tissues from the chemotherapy even when administered at high doses. For example, a cancer patient taking chemotherapy and AGT inhibitors could at the same time receive an infusion of modified bone marrow cells that would have a form of AGT protein able to resist the inhibitors, which could protect the patient from some of chemotherapy's more toxic side effects.

Daniels and Tainer had already solved the free-form structure of AGT (not bound to DNA), and when they compared this to the DNA-bound form, they found that the structures were identical. The fact that AGT's structure does not change after binding the DNA suggests a simple one-step pathway whereby AGT repairs damaged DNA.

The model that Daniels, Tainer, Pegg, and their colleagues are suggesting is one of twist and grab.

AGT recognizes a piece of DNA that is damaged and binds to that DNA. Then it twists out the phosphate backbone of the DNA, exposing the damaged base, repairs the base by grabbing the offending alkyl group and transferring it onto itself, and releases the now repaired section of DNA. In doing so, the protein is used up.

DNA commonly twists in such a way that there is a major groove (like the part of the staircase with the steps) and a minor groove (like the part with the rail). One of the details that has emerged from this study is that AGT recognizes the minor groove of DNA.

Most proteins that bind to DNA bind in
'"/>

Contact: Jason Bardi
jasonb@scripps.edu
858-784-9254
Scripps Research Institute
7-Jul-2004


Page: 1 2 3 4

Related biology news :

1. Structure solved by Scripps scientists shows one way that body controls gene expression
2. Structure of a Nobel-prize winning molecule: Aquaporin
3. Structure of HIV-neutralizing antibody solved
4. Structure of key breast cancer receptor determined
5. Structure of cog at the hub of metabolism reveals anti-ageing function
6. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
7. Structure reveals details of cells cargo-carriers
8. Structure of key receptor unlocked; Related proteins will fall like dominoes
9. New Science Press launches Proteins: From Sequence to Structure
10. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
11. Structure of key protein involved in cancer, osteoporosis and foot-and-mouth disease finally solved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 17, 2019 , ... ... and its acclaimed pediatric urologists are among the professionals honored in U.S. ... signifies excellence among the country’s pediatric healthcare landscape. , Georgia Urology’s wholly-owned ...
(Date:7/10/2019)... ... July 10, 2019 , ... Inference ... and service organizations, today announced its role in Pizza Hut Australia’s digital ... of its franchisees. A key part of this initiative is implementation of an ...
(Date:6/27/2019)... ... 2019 , ... Lighting designers from integrated design firm LPA recently ... for creating both engaging and energy efficient lighting systems. , The lighting for the ... San Diego, California earned an IES Illumination Award of Merit in the Energy and ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las ... R3 Heroes Program. The Veterans included individuals and families from all over the US, ... a military Veteran, teacher or first responder to receive a regenerative therapy at a ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , ... library of more than 20 million articles, sourced from more than 15,000 journals. ...
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, ... immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) cell ... as “CARs”. The CAR enables the final product to produce chemicals in the hopes ...
Breaking Biology Technology:
Cached News: